Korean J Gastroenterol.  2020 Jul;76(1):52-54. 10.4166/kjg.2020.76.1.52.

Usefulness of the Number of Reflux Episodes on pH-impedance Monitoring in Predicting Treatment Outcome in Patients with Gastroesophageal Reflux Disease

• Gong EJ

• KMID: 2504596
• DOI: http://doi.org/10.4166/kjg.2020.76.1.52

Reference

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. 2006; The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 101:1900–1920. quiz 1943DOI: 10.1111/j.1572-0241.2006.00630.x. PMID: 16928254.

2. Gyawali CP, Kahrilas PJ, Savarino E, et al. 2018; Modern diagnosis of GERD: the Lyon Consensus. Gut. 67:1351–1362. DOI: 10.1136/gutjnl-2017-314722. PMID: 29437910. PMCID: PMC6031267.

3. Roman S, Gyawali CP, Savarino E, et al. 2017; Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 29:1–15. DOI: 10.1111/nmo.13067. PMID: 28370768.

4. Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation. Gut. 2020 May 28. [Epub ahead of print]. DOI: 10.1136/gutjnl-2020-321395. PMID: 32467089.

5. Bell R, Lipham J, Louie B, et al. 2019; Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc. 89:14–22.e1. DOI: 10.1016/j.gie.2018.07.007. PMID: 30031018.

6. Bell R, Lipham J, Louie BE, et al. 2020; Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation in a 1-year randomized trial. Clin Gastroenterol Hepatol. 18:1736–1743.e2. DOI: 10.1016/j.cgh.2019.08.056. PMID: 31518717.

7. Kahrilas PJ, Boeckxstaens G, Smout AJ. 2013; Management of the patient with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol. 27:401–414. DOI: 10.1016/j.bpg.2013.06.005. PMID: 23998978. PMCID: PMC3761380.

8. Dent J, Vakil N, Jones R, et al. 2010; Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 59:714–721. DOI: 10.1136/gut.2009.200063. PMID: 20551454.

9. Patel A, Sayuk GS, Gyawali CP. 2015; Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 13:884–891. DOI: 10.1016/j.cgh.2014.08.029. PMID: 25158924. PMCID: PMC4339660.

10. Frazzoni M, Savarino E, de Bortoli N, et al. 2016; Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedancepH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 14:40–46. DOI: 10.1016/j.cgh.2015.06.026. PMID: 26122764.

11. Roman S, Bruley des Varannes S, Pouderoux P, et al. 2006; Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 18:978–986. DOI: 10.1111/j.1365-2982.2006.00825.x. PMID: 17040408.